Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).

Clinical trial NCT04687982 · COMPLETED

Trial details

NCT number: NCT04687982
Sponsor: Istituto Clinico Humanitas
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Bone Marrow Transplant Infection Bone Marrow Transplant Complications Graft Vs Host Disease Infection Hematological Malignancy

Start date: 2018-11-13
Primary completion: 2020-01-08
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.